Pro Medicus Limited
PME
Rank in Stocks
#1627
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Share Price
$126.25
Market Cap
$13.19B
Change (1 day)
-0.30%
Change (1 year)
-32.46%
Country
AU
Trade Pro Medicus Limited (PME)
Category
Healthcare
Number of shares outstanding for Pro Medicus Limited (PME)
Number of shares outstanding as of June 2026: 104.47M
According to Pro Medicus Limited latest financial reports and stock price the company's current number of shares outstanding is 104.47M. At the end of June 2024 the company had 104.44M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Pro Medicus Limited (PME) from 2000 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 104.47M | -0.01% |
| 2025 | 104.48M | 0.03% |
| 2024 | 104.44M | 0.03% |
| 2023 | 104.41M | 0.09% |
| 2022 | 104.31M | 0.14% |
| 2021 | 104.17M | 0.26% |
| 2020 | 103.90M | 0.31% |
| 2019 | 103.57M | 0.37% |
| 2018 | 103.19M | 0.69% |
| 2017 | 102.49M | 1.09% |
| 2016 | 101.38M | 1.11% |
| 2015 | 100.26M | 0.00% |
| 2014 | 100.26M | 0.92% |
| 2013 | 99.35M | -0.91% |
| 2012 | 100.26M | -0.02% |
| 2011 | 100.28M | 0.00% |
| 2010 | 100.28M | 0.00% |
| 2009 | 100.28M | 0.00% |
| 2008 | 100.28M | 0.26% |
| 2007 | 100.02M | 0.02% |
| 2006 | 100.00M | 0.00% |
| 2005 | 100.00M | 0.00% |
| 2004 | 100.00M | 0.00% |
| 2003 | 100.00M | 0.00% |
| 2002 | 100.00M | 0.00% |
| 2001 | 100.00M | 0.00% |
| 2000 | 100.00M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 453.00M | 333.62% |
US
|
|
| 205.38M | 96.59% |
US
|
|
| 179.92M | 72.22% |
US
|
|
| 129.98M | 24.42% |
US
|
|
| - | - |
US
|
